Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

Share Price is delayed by 15 minutes
Get Live Data
37.00    0.00 (0.00%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £33.82m
EMAN Live PriceLast checked at - London Stock Exchange

Intraday Everyman Media Share Chart

Trading Update

10 Dec 2025 07:00

RNS Number : 9130K
Everyman Media Group PLC
10 December 2025
 

10 December 2025

Everyman Media Group PLC

("Everyman" or the "Group")

 

Trading Update

 

Everyman Media Group plc (AIM: EMAN), the independent, premium cinema group, provides an update for the year ended 01 January 2026 ("FY25").

 

As previously reported, the Group is operating in a challenging economic environment. Despite these challenges, the Group is on track to achieve growth across all key metrics in FY25, including improvements in revenue, EBITDA, F&B spend per head, paid-for average ticket price and market share.

 

However, as widely reported, UK Box Office performance in Q4 FY25 has been weaker than anticipated. As a consequence of this, the Board now expects Group revenue of no less than £114.5m (FY24: £107.2m) and EBITDA of no less than £16.8m (FY24: £16.2m)1. Accordingly, net debt is now expected to be approximately £24.0m at period end (2024: £18.1m). It is worth noting that FY24, as a 53-week period, contained an additional trading week compared to FY25. On a comparable 52-week basis, FY24 revenue would have been £103.8m and EBITDA £15.4m, reflecting further year-on-year growth in these metrics in FY25.

 

The Group expects to release a further trading update for FY25 and amended guidance on its outlook for future years in January 2026.

 

Alex Scrimgeour, CEO of Everyman Media Group Plc, said: "Notwithstanding the industry-wide challenges, to date this has been a year of progress in which we have achieved growth across our core operating metrics, delivering increased revenue, EBITDA and customer spend per head, as well as strong membership growth and expanding market share. The continued growth in customer satisfaction reflects our commitment to delivering the premium experience across our estate, and with our market leading position, we remain confident in the long-term growth opportunity in the premium cinema sector".

 

 1 In so far as the Board is aware, prior to this announcement, current consensus market expectations for FY25 were revenue of £121.5m and EBITDA of £19.9m

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

 

Everyman Media Group plc

Tel: 020 3145 0500

Alex Scrimgeour, Chief Executive

Will Worsdell, Finance Director

 

Canaccord Genuity Limited (NOMAD and Broker)

Tel: 020 7523 8000

Bobbie Hilliam

Elizabeth Halley-Stott

Alma (Financial PR Advisor)

Tel: 020 3405 0205

Rebecca Sanders-Hewett

everyman@almastrategic.com

Joe Pederzolli

Emma Thompson

 

About Everyman Media Group PLC:

 

Everyman is the fourth largest cinema business in the UK by number of venues, and is a premium, high growth leisure brand. Everyman operates a growing estate of venues across the UK, with an emphasis on providing first class cinema and hospitality.

 

Everyman is redefining cinema. It focuses on venue and experience as key competitive strengths, with a unique proposition:

 

·

Intimate and atmospheric venues, which become a destination in their own right

·

An emphasis on a strong quality food and drink menu prepared in-house

·

A broad range of well-curated programming content, from mainstream and independent films to theatre and live concert streams, appealing to a diverse range of audiences

·

Motivated and welcoming teams

 

For more information visit http://investors.everymancinema.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKCBNCBDDDBK
Date   Source Headline
2nd Jun 20268:47 amRNSPDMR Shareholding
29th May 202611:56 amRNSPDMR Dealing
27th May 20269:23 amRNSPosting of Annual Report and Notice of AGM
21st May 20265:04 pmRNSPDMR Shareholding
6th May 20267:00 amRNSExercise of Options and Total Voting Rights
5th May 20267:00 amRNSExercise of Options and Total Voting Rights
5th May 20267:00 amRNSPDMR Dealing
28th Apr 20267:00 amRNSFull Year Results to 1 January 2026
21st Apr 20267:00 amRNSBoard Update and Notice of Results
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 202610:58 amRNSDirector/PDMR Shareholding
26th Mar 20265:08 pmRNSNotification of major holdings
26th Mar 20265:01 pmRNSNotification of major holdings
23rd Mar 20261:26 pmRNSDirector/PDMR Shareholding
16th Mar 20269:04 amRNSDirector/PDMR Shareholding
16th Mar 20269:04 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSGrant of Options
11th Mar 20267:00 amRNSGrant of Options
6th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSBoard Appointments
27th Jan 20267:00 amRNSTrading Update
29th Dec 20257:00 amRNSBoard change
29th Dec 20257:00 amRNSBoard change
16th Dec 20252:47 pmRNSNotification of major holdings
15th Dec 20257:00 amRNSBoard change
10th Dec 20257:00 amRNSTrading Update
24th Sep 20257:02 amRNSChange of Options Terms
24th Sep 20257:01 amRNSAppointment of Non-Executive Director
24th Sep 20257:00 amRNSInterim Results
28th Jul 20257:00 amRNSTrading Update
19th Jun 20251:24 pmRNSResult of AGM
20th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
9th May 20257:00 amRNSDirector / PDMR Shareholding
15th Apr 20257:01 amRNSGrant of Options
15th Apr 20257:00 amRNSPreliminary Results to 02 January 2025
2nd Apr 20257:00 amRNSNotice of Results
17th Jan 20257:00 amRNSTrading Update
25th Sep 20247:00 amRNSInterim Results
16th Aug 20247:00 amRNSExercise of Options and Total Voting Rights
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSTrading Update and Notice of Results
13th Jun 20243:45 pmRNSResult of AGM
17th May 20247:00 amRNSNotice of AGM
18th Apr 20249:17 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSGrant of Options
16th Apr 20247:00 amRNSFinal Results to 28 December 2023
28th Mar 20247:00 amRNSNotice of Results and Investor Presentation
9th Feb 202412:45 pmRNSCorrection: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.